Acurx Pharmaceuticals Files Registration Statement for Resale of Common Stock by Lincoln Park Capital

Filing content

The company filed a registration statement for the resale of up to 1,500,000 shares of common stock by Lincoln Park Capital. This filing relates to resale registration under an existing agreement, not a new issuance.